Pages that link to "Q24621753"
Jump to navigation
Jump to search
The following pages link to IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells (Q24621753):
Displaying 50 items.
- Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells (Q24530100) (← links)
- CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. (Q24540429) (← links)
- Adoptive immunotherapy for cancer: building on success (Q24546258) (← links)
- Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma (Q24548019) (← links)
- Cancer immunotherapy: moving beyond current vaccines (Q24548229) (← links)
- Interleukin-15 biology and its therapeutic implications in cancer (Q24595605) (← links)
- T cell receptor gene therapy for cancer (Q24634774) (← links)
- Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors (Q26741260) (← links)
- Cancer immunotherapy: the beginning of the end of cancer? (Q26752277) (← links)
- Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy (Q26752955) (← links)
- Developing Combined HIV Vaccine Strategies for a Functional Cure (Q26998898) (← links)
- Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? (Q27002575) (← links)
- Novel immunotherapies for hematologic malignancies (Q27004436) (← links)
- Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques (Q27314843) (← links)
- Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing (Q27334215) (← links)
- Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination (Q28068378) (← links)
- Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic (Q28075992) (← links)
- Concepts of immunotherapy for glioma (Q28083888) (← links)
- IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy (Q28088543) (← links)
- Harnessing the Microbiome to Enhance Cancer Immunotherapy (Q28088598) (← links)
- The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy (Q28088784) (← links)
- Adoptive immunotherapy for cancer: harnessing the T cell response (Q28262548) (← links)
- Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation (Q28270256) (← links)
- BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models (Q28828457) (← links)
- A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function (Q33281005) (← links)
- Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer (Q33418729) (← links)
- T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies (Q33530527) (← links)
- Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling (Q33601367) (← links)
- Novel human interleukin-15 agonists (Q33623266) (← links)
- IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo (Q33660150) (← links)
- Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2 (Q33680751) (← links)
- Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8+ T Cells with Broad Antitumor Capacity. (Q33715829) (← links)
- The role of interleukin-15 polymorphisms in adult acute lymphoblastic leukemia (Q33737761) (← links)
- Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression (Q33738154) (← links)
- Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo (Q33760403) (← links)
- Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells (Q33801773) (← links)
- Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells (Q33831940) (← links)
- IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice (Q33839836) (← links)
- Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens (Q33849560) (← links)
- Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice (Q33863928) (← links)
- Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression (Q33903025) (← links)
- CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. (Q34063120) (← links)
- Alphavirus vectors for cancer therapy. (Q34130212) (← links)
- Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors (Q34205181) (← links)
- Characterization of human T lymphocytes engineered to express interleukin-15 and herpes simplex virus-thymidine kinase (Q34338927) (← links)
- Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis (Q34415755) (← links)
- Ex vivo development, expansion and in vivoanalysis of a novel lineage of dendritic cells from hematopoietic stem cells (Q34419349) (← links)
- Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. (Q34422330) (← links)
- Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells. (Q34428078) (← links)
- Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy (Q34533728) (← links)